Standout Papers
Citation Impact
Citing Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
2006 Standout
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia
2003
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 Standout
Prevalence, Determinants, and Molecular Epidemiology of Streptococcus pneumoniae Isolates Colonizing the Nasopharynx of Healthy Children in Rome
2002
Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy
2003
Immunization of pediatric solid‐organ transplantation candidates: Immunizations in transplant candidates
2005
Potential Contribution by Nontypable Haemophilus influenzae in Protracted and Recurrent Acute Otitis Media
2009
Use of mass media campaigns to change health behaviour
2010 Standout
Nationwide Surveillance of NasopharyngealStreptococcus pneumoniaeIsolates from Children with Respiratory Infection, Switzerland, 1998–1999
2003
Efficacy and Safety of a Live Attenuated, Cold-Adapted Influenza Vaccine, Trivalent Against Culture-Confirmed Influenza in Young Children in Asia
2007
Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine
2004
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals
2016 Standout
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
2009 Standout
Spread ofStreptococcus pneumoniaeand Antibiotic‐ResistantS. pneumoniaefrom Day‐Care Center Attendees to Their Younger Siblings
2002
Seven-Valent Pneumococcal Conjugate Vaccine in Pediatric Solid Organ Transplant Recipients
2009
Global burden of childhood pneumonia and diarrhoea
2013 Standout
Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
2003 Standout
Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants
2000
Effects of the Live Attenuated Measles-Mumps-Rubella Booster Vaccination on Disease Activity in Patients With Juvenile Idiopathic Arthritis
2013
Dual Detection of Fungal Infections in Drosophila via Recognition of Glucans and Sensing of Virulence Factors
2006 StandoutNobel
Child and adolescent mental health worldwide: evidence for action
2011 Standout
Prevention of otitis media: Role of pneumococcal conjugate vaccines in reducing incidence and antibiotic resistance
2002
Recent Advances in Otitis Media
2009
Natural history of untreated otitis media
2003
Juvenile idiopathic arthritis
2007 Standout
The Diagnosis and Management of Acute Otitis Media
2013 Standout
Streptococcus pneumoniae colonisation: the key to pneumococcal disease
2004 Standout
Pneumococcal serotypes from acute otitis media in rural Kentucky
2002
Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
2007 Standout
Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell Transplantation
2009
Clinical efficacy of anti-pneumococcal vaccination in patients with COPD
2005
Pneumococcal conjugate vaccines: proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy
2003
The Burden of Respiratory Syncytial Virus Infection in Young Children
2009 Standout
Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study
2006
Response to Pneumococcal (PNCRM7) and Haemophilus Influenzae Conjugate Vaccines (HIB) in Pediatric and Adult Recipients of an Allogeneic Hematopoietic Cell Transplantation (alloHCT)
2008
Cochlear Implants in Children: Surgical Site Infections and Prevention and Treatment of Acute Otitis Media and Meningitis
2010
IMMUNOGENICITY OF THE SEVEN VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PATIENTS WITH ATAXIA-TELANGIECTASIA
2004
How to compare the efficacy of conjugate vaccines to prevent acute otitis media?
2009
Prevention of otitis media: Now a reality?
2009
A role for Streptococcus pneumoniae in virus-associated pneumonia
2004
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
2006
Immunogenicity of Pneumococcal Vaccine in Renal Transplant Recipients—Three Year Follow‐up of a Randomized Trial
2007
Safety and Immunogenicity of a Heptavalent Pneumococcal Conjugate Vaccine in Infants With Human Immunodeficiency Virus Type 1 Infection
2003
Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections
2006
Epidemiology of Invasive <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> Infections in the United States, 1995-1998<SUBTITLE>Opportunities for Prevention in the Conjugate Vaccine Era</SUBTITLE>
2001
Cold-adapted, live attenuated influenza vaccine
2004
Global, regional, and national causes of child mortality in 2008: a systematic analysis
2010 Standout
Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting
2009
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
2005
ACYCLOVIR-RESISTANT CHRONIC VERRUCOUS VACCINE STRAIN VARICELLA IN A PATIENT WITH NEUROBLASTOMA
2008
U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
2013
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis
2007
Efficacy of Intranasal Virosomal Influenza Vaccine in the Prevention of Recurrent Acute Otitis Media in Children
2002
Clinical Features and Prognostic Factors in Adults with Bacterial Meningitis
2004 Standout
Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children
2006
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
2005 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Is Bilateral Acute Otitis Media Clinically Different Than Unilateral Acute Otitis Media?
2007
A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults
2010
Graft-versus-host disease
2009 Standout
Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United States
2000
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
2004 Standout
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000
2012 Standout
Lower Respiratory Tract Infections Among American Indian and Alaska Native Children and the General Population of U.S. Children
2005
Nasopharyngeal Carriage ofStreptococcus pneumoniaein Finnish Children Younger Than 2 Years Old
2001
Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group
2015 Standout
Antimicrobial Use and Colonization with Erythromycin‐ResistantStreptococcus pneumoniaein Greece during the First 2 Years of Life
2000
Vaccines for Transplant Recipients
2001
Do Antibodies to Pneumococcal Surface Adhesin A Prevent Pneumococcal Involvement in Acute Otitis Media?
2001
Sickle-cell disease
2010 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?
2013 Standout
Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults
2003
Autism
2013 Standout
Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model
2000
Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae?
2003
Emergence of a Multiresistant Serotype 19A Pneumococcal Strain Not Included in the 7-Valent Conjugate Vaccine as an Otopathogen in Children
2007
Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I
2000
What works? Interventions for maternal and child undernutrition and survival
2008 Standout
Safety, Efficacy, and Effectiveness of Cold-Adapted Influenza Vaccine-Trivalent Against Community-Acquired, Culture-Confirmed Influenza in Young Children Attending Day Care
2006
Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study
2001
Physical activity and mental health in children and adolescents: a review of reviews
2011 Standout
Community-Wide Vaccination with the Heptavalent Pneumococcal Conjugate Significantly Alters the Microbiology of Acute Otitis Media
2004
Comparison of the Efficacy and Safety of Live Attenuated Cold-Adapted Influenza Vaccine, Trivalent, With Trivalent Inactivated Influenza Virus Vaccine in Children and Adolescents With Asthma
2006
Evolving Microbiology and Molecular Epidemiology of Acute Otitis Media in the Pneumococcal Conjugate Vaccine Era
2007
Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study
2002
Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States
2003
Prospects for Prevention of Otitis Media
2007
Reduction of Nasopharyngeal Carriage ofStreptococcus pneumoniaeafter Administration of a 9‐Valent Pneumococcal Conjugate Vaccine to Toddlers Attending Day Care Centers
2002
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
2001 Standout
Immunogenicity, Safety, and Predictors of Response After a Pneumococcal Conjugate and Pneumococcal Polysaccharide Vaccine Series in Human Immunodeficiency Virus-Infected Children Receiving Highly Active Antiretroviral Therapy
2006
Infection in Solid-Organ Transplant Recipients
2007 Standout
Technical Report: Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate and Polysaccharide Vaccines and Antibiotic Prophylaxis
2000
Use of vaccines as probes to define disease burden
2014
Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine
2001
Immunological responses to pneumococcal vaccine in frail older people
2008
Prerequisites for global child and adolescent mental health
2009
Herpes Zoster
2013 Standout
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
2003 Standout
Efficacy of an 11-Valent Pneumococcal Conjugate Vaccine Against Radiologically Confirmed Pneumonia Among Children Less Than 2 Years of Age in the Philippines
2009
The Changing Epidemiology of Bacterial Meningitis and Invasive Non-meningitic Bacterial Disease in Scotland During the Period 1983-99
2002
Clonal Relationships between Invasive and CarriageStreptococcus pneumoniaeand Serotype‐ and Clone‐Specific Differences in Invasive Disease Potential
2003
Developmental potential in the first 5 years for children in developing countries
2007 Standout
Frailty in elderly people
2013 Standout
Acute Otitis Media Due to Penicillin-Nonsusceptible Streptococcus pneumoniae Before and After the Introduction of the Pneumococcal Conjugate Vaccine
2005
A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection
2003
Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis
2014 Standout
Impact of conjugate pneumococcal vaccines on antibiotic resistance
2008
Quantitative and Qualitative Anamnestic Immune Responses to Pneumococcal Conjugate Vaccine in HIV‐Infected and HIV‐Uninfected Children 5 Years after Vaccination
2009
Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization among Immunized and Unimmunized Children in a Community‐Randomized Trial
2007
Immunization of Humans with Recombinant Pneumococcal Surface Protein A (rPspA) Elicits Antibodies That Passively Protect Mice from Fatal Infection withStreptococcus pneumoniaeBearing Heterologous PspA
2000
How many child deaths can we prevent this year?
2003 Standout
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules
2000
Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination
2003
Observation option toolkit for acute otitis media
2001
Changes in Frequency and Pathogens Causing Acute Otitis Media in 1995–2003
2004
Complementary and Alternative Medicine in Autism: An Evidence-Based Approach to Negotiating Safe and Efficacious Interventions with Families
2010
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Nasopharyngeal Carriage ofStreptococcus pneumoniaein Healthy Children: Implications for the Use of Heptavalent Pnemococcal Conjugate Vaccine
2002
Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1996
Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age
2009
10-valent pneumococcal nontypeableHaemophilus influenzaePD conjugate vaccine: Synflorix™
2009
Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial
2005
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
2009 Standout
Pneumococcal conjugate vaccines for preventing otitis media
2014
Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia
2005
Intranasal Immunization of Mice with a Mixture of the Pneumococcal Proteins PsaA and PspA Is Highly Protective against Nasopharyngeal Carriage ofStreptococcus pneumoniae
2000
Prevention and Control of Seasonal Influenza with Vaccines
2016
Emerging infectious diseases in the 21st century
2000
Otitis media
2004
Acute otitis media in pediatric medicine: current issues in epidemiology, diagnosis, and management.
2003
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
2009 Standout
Insights into the Interaction between Influenza Virus and Pneumococcus
2006
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Using the shortwave infrared to image middle ear pathologies
2016 StandoutNobel
Intranasal Vaccination with Pneumococcal Surface Protein A and Interleukin-12 Augments Antibody-Mediated Opsonization and Protective Immunity againstStreptococcus pneumoniaeInfection
2001
Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non‐typable Haemophilus influenzae: a randomised double‐blind efficacy study
2006
Pneumococcal Carriage in Children in The Netherlands: a Molecular Epidemiological Study
2001
Safety and Immunogenicity of the American Academy of Pediatrics–Recommended Sequential Pneumococcal Conjugate and Polysaccharide Vaccine Schedule in Pediatric Solid Organ Transplant Recipients
2005
Molecular pathogenesis of pneumococcal pneumonia
2001
Inhibition of Pneumococcal Adherence to Human Nasopharyngeal Epithelial Cells by Anti-PsaA Antibodies
2003
Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection
2003
Efficacy of Pneumococcal Vaccination in Children Younger Than 24 Months: A Meta-Analysis
2009
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
2008 Standout
New Vaccines Against Otitis Media: Projected Benefits and Cost-effectiveness
2009
Reduction of Frequent Otitis Media and Pressure-Equalizing Tube Insertions in Children After Introduction of Pneumococcal Conjugate Vaccine
2007
Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study
2003
Trends in Acute Otitis Media-Related Health Care Utilization by Privately Insured Young Children in the United States, 1997–2004
2008
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
National Impact of Universal Childhood Immunization With Pneumococcal Conjugate Vaccine on Outpatient Medical Care Visits in the United States
2006
Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults
2007
Pneumococcal Resistance and Serotype 19A in Pittsburgh-Area Children With Acute Otitis Media Before and After Introduction of 7-Valent Pneumococcal Polysaccharide Vaccine
2010
Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation
2003
Ability of Pneumococcal Serotypes and Clones To Cause Acute Otitis Media: Implications for the Prevention of Otitis Media by Conjugate Vaccines
2003
Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation
2006
Population-Based Impact of Pneumococcal Conjugate Vaccine in Young Children
2004
Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Bacterial Colonization During Acute Otitis Media
2006
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of Paula Ray being referenced
Immunogenicity and Safety of Measles-Mumps-Rubella, Varicella and Haemophilus influenzae Type b Vaccines Administered Concurrently With a Fourth Dose of Heptavalent Pneumococcal Conjugate Vaccine Compared With the Vaccines Administered Without Heptavalent Pneumococcal Conjugate Vaccine
2006
Quality of HMO Vaccination Databases Used to Monitor Childhood Vaccine Safety
1999
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
2000 Standout
Lack of Association between Age at Varicella Vaccination and Risk of Breakthrough Varicella, within the Northern California Kaiser Permanente Medical Care Program
2008
Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers
1999
Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants
2002
Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents
2004
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia
2002
Effectiveness of Heptavalent Pneumococcal Conjugate Vaccine in Children Younger Than 5 Years of Age for Prevention of Pneumonia
2006
Risk factors for delayed immunization among children in an HMO.
1994
Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease
2001
Postmarketing evaluation of the safety and effectiveness of varicella vaccine
1999
Early Thimerosal Exposure and Neuropsychological Outcomes at 7 to 10 Years
2007
Impact of the pneumococcal conjugate vaccine on otitis media
2003
Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy
1993
Risk of Chronic Arthropathy Among Women After Rubella Vaccination
1997
Efficacy of Heptavalent Conjugate Pneumococcal Vaccine (Wyeth Lederle) in 7,000 Infants and Children: Results of the Northern California Kaiser Permanente Efficacy Trial
1999
Long-term Effectiveness of Varicella Vaccine: A 14-Year, Prospective Cohort Study
2013
Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures
2010